Format

Send to

Choose Destination
Int Rev Immunol. 2004 Sep-Dec;23(5-6):437-45.

Application of VIP/NTM-reactive natural antibodies in therapy of HIV disease.

Author information

1
Center for Multidisciplinary Research, Institute of Nuclear Sciences VINCA, Belgrade, Yugoslavia. veljko01@hotmail.com

Abstract

In sera of HIV-infected individuals natural antibodies recognizing nonimmunogenic C-terminal domain of the second conserved region of HIV-1 gp120 and the vasoactive intestinal peptide (VIP) were identified. It has been demonstrated that these antibodies are significantly more prevalent in asymptomatic carriers than in AIDS patients and that their titer strongly correlates with disease progression. These findings point out the VIP/C2-reactive natural antibodies as an important agent for immunotherapy of HIV disease.

PMID:
15370275
DOI:
10.1080/08830180490432820
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center